Device Trial Radar · NCT05230992
Optimization of the Sensitivity of Histological Diagnosis of Pulmonary Nodules
Last checked: Nov 19, 2026Latest source record: Feb 14, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Nov 5, 2022
Primary completion
Nov 30, 2023
Study completion Dec 31, 2023
Sponsor
- Lead sponsor
- ElsanAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Feb 9, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
In pulmonary oncology, the diagnosis of medium-sized pulmonary nodules (10 to 20 mm), too distal to be reached by standard bronchial fibroscopy but remaining proximal, is difficult. There are 2 techniques: transthoracic puncture-biopsy under CT scan, usually performed by radiologists, and distal sampling guided by radial ultrasound mini-probe. The limitations of the last technique could be overcome by the use of cryoprobes for sampling, as they would take more tissue by freezing.
Conditions
- Nodule
Interventions
Cryoprobes FirstDevice
In this experimental group, the Cryoprobe is used in first and the classic biopsy forceps in a second time. This medical device under study is the flexible, single-use Cryoprobe, supplied in sterile condition, 1.1 mm in diameter, 1150 mm long, with extraction tube, 817 mm long (reference 20402-401), or 757 mm long (reference 20402-402) marketed. These cryoprobes are covered by a CE marking. Cryoprobes must be used in conjunction with the Erbecryo®2 device and its accessories.
Cryoprobes SecondDevice
In this second experimental group, the same medical devices are used but in the other order.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Validity of samples by cryoprobesTime frame: Within 24 hours after intervention
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Pneumologie Elsan Santé Atlantique
Saint-Herblain, France
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.